The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer
Open accessAbstract
Cancer cells must integrate multiple biosynthetic demands to drive indefinite proliferation. How these key cellular processes, such as metabolism and protein synthesis, crosstalk to fuel cancer cell growth is unknown. Here, we uncover the mechanism by which the Myc oncogene coordinates the production of the two most abundant classes of cellular macromolecules, proteins, and nucleic acids in cancer cells. We find that a single rate-limiting enzyme, phosphoribosyl-pyrophosphate synthetase 2 (PRPS2), promotes increased nucleotide biosynthesis in Myc-transformed cells. Remarkably, Prps2 couples protein and nucleotide biosynthesis through a specialized cis-regulatory element within the Prps2 5' UTR, which is controlled by the oncogene and translation initiation factor eIF4E downstream Myc activation. We demonstrate with a Prps2 knockout mouse that the nexus between protein and nucleotide biosynthesis controlled by PRPS2 is crucial for Myc-driven tumorigenesis. Together, these studies identify a translationally anchored anabolic circuit critical for cancer cell survival and an unexpected vulnerability for "undruggable" oncogenes, such as Myc. PAPERFLICK:
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the c-myc-regulated targets are phosphoribosyl pyrophosphate synthetase 2 (PRPS2), which catalyzes a first step of purine biosynthesis, as well as carbamoyl phosphate synthetase II (CAD), which initiates the pyrimidine ring-building cascade (Cunningham et al., 2014; Eberhardy and Farnham, 2001; Mannava et al., 2008).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Cunningham et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Hwang, T., & Shaka, A. J. (1995) · Journal of Magnetic Resonance Series A · doi:10.1006/jmra.1995.1047 · Cited by 1,929
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Dieterle, F., Ross, A., Schlotterbeck, G., & Senn, H. (2006) · Analytical Chemistry · doi:10.1021/ac051632c · Cited by 1,772
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313
Self-citationMetabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α
Gerhart‐Hines, Z., Rodgers, J. T., Bare, O., Lerin, C., Kim, S., Mostoslavsky, R., Alt, F. W., Wu, Z., & Puigserver, P. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601633 · Cited by 1,294
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., Dupuy, F., Chambers, C., Fuerth, B. J., Viollet, B., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.001 · Cited by 949
Cited by
Sorted by citations
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism
Hoxhaj, G., & Manning, B. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0216-7 · Cited by 2,137
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,435
mTOR signalling and cellular metabolism are mutual determinants in cancer
Mossmann, D., Park, S., & Hall, M. N. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0074-8 · Cited by 1,088
Regulation of mammalian nucleotide metabolism and biosynthesis
Lane, A. N., & Fan, T. W.-M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv047 · Cited by 959
Targeting the translation machinery in cancer
Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4505 · Cited by 799
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
Zhang, J., Pavlova, N. N., & Thompson, C. B. (2017) · The EMBO Journal · doi:10.15252/embj.201696151 · Cited by 651
mTORC1 signaling and the metabolic control of cell growth
Ben‐Sahra, I., & Manning, B. D. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.02.012 · Cited by 668
Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
Schiliro, C., & Firestein, B. L. (2021) · Cells · doi:10.3390/cells10051056 · Cited by 659
mTOR coordinates protein synthesis, mitochondrial activity and proliferation
Morita, M., Gravel, S.-P., Hulea, L., Larsson, O., Pollak, M., St-Pierre, J., & Topisirovic, I. (2015) · Cell Cycle · doi:10.4161/15384101.2014.991572 · Cited by 552
MYC: Connecting selective transcriptional control to global RNA production
Kress, T. R., Sabò, A., & Amati, B. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3984 · Cited by 521
Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor
Krall, A. S., Xu, S., Graeber, T. G., Braas, D., & Christofk, H. R. (2016) · Nature Communications · doi:10.1038/ncomms11457 · Cited by 504
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Hsu, T. Y. T., Simon, L. M., Neill, N. J., Marcotte, R., Sayad, A., Bland, C. S., Echeverria, G. V., Sun, T., Kurley, S. J., Tyagi, S., et al. (2015) · Nature · doi:10.1038/nature14985 · Cited by 498
Regulation of cancer cell metabolism: Oncogenic MYC in the driver’s seat
Dong, Y., Tu, R., Liu, H., & Qing, G. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00235-2 · Cited by 405
New frontiers in translational control of the cancer genome
Truitt, M. L., & Ruggero, D. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.27 · Cited by 378
Self-citationDifferential Requirements for eIF4E Dose in Normal Development and Cancer
Truitt, M., Conn, C. S., Shi, Z., Pang, X., Tokuyasu, T. A., Coady, A. M., Seo, Y., Barna, M., & Ruggero, D. (2015) · Cell · doi:10.1016/j.cell.2015.05.049 · Cited by 383
Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
Pelletier, J., Graff, J., Ruggero, D., & Sonenberg, N. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2789 · Cited by 367
Self-citationMYC and metabolism on the path to cancer
Hsieh, A. L., Walton, Z. E., Altman, B. J., Stine, Z. E., & Dang, C. V. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.08.003 · Cited by 347
Molecular logic of mTORC1 signalling as a metabolic rheostat
Valvezan, A. J., & Manning, B. D. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0038-7 · Cited by 310
Erratum: New frontiers in translational control of the cancer genome
Truitt, M., & Ruggero, D. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.30 · Cited by 306
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer
Fontana, F., Giannitti, G., Marchesi, S., & Limonta, P. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.89942 · Cited by 309
Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
Villa, E., Ali, E. S., Sahu, U., & Ben‐Sahra, I. (2019) · Cancers · doi:10.3390/cancers11050688 · Cited by 289
The plasticity of mRNA translation during cancer progression and therapy resistance
Fabbri, L., Chakraborty, A., Robert, C., & Vagner, S. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00380-y · Cited by 286
Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming
Adeshakin, F. O., Adeshakin, A. O., Afolabi, L. O., Yan, D., Zhang, G., & Wan, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.626577 · Cited by 277
ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression
Tameire, F., Verginadis, I. I., Leli, N. M., Polte, C., Conn, C. S., Ojha, R., Salinas, C. S., Chinga, F., Monroy, A. M., Fu, W., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0347-9 · Cited by 269
Phosphoribosyl Diphosphate (PRPP): Biosynthesis, Enzymology, Utilization, and Metabolic Significance
Hove‐Jensen, B., Andersen, K. R., Kilstrup, M., Martinussen, J., Switzer, R. L., & Willemoës, M. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00040-16 · Cited by 274
Kodama, M. (2020) · Institutional Repositories DataBase (IRDB) · Cited by 267
Pyruvate Kinase Isoform Expression Alters Nucleotide Synthesis to Impact Cell Proliferation
Lunt, S. Y., Muralidhar, V., Hosios, A. M., Israelsen, W. J., Gui, D. Y., Newhouse, L., Ogrodzinski, M. P., Hecht, V. C., Xu, K., Acevedo, P. N. M., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.027 · Cited by 263
MYC and tumor metabolism: chicken and egg
Dejure, F. R., & Eilers, M. (2017) · The EMBO Journal · doi:10.15252/embj.201796438 · Cited by 240
A non-proliferative role of pyrimidine metabolism in cancer
Siddiqui, A., & Ceppi, P. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.02.005 · Cited by 223
Targeting mTOR and Metabolism in Cancer: Lessons and Innovations
Magaway, C., Kim, E., & Jacinto, E. (2019) · Cells · doi:10.3390/cells8121584 · Cited by 231
Li, X., Qian, X., Peng, L.-X., Jiang, Y., Hawke, D. H., Zheng, Y., Xia, Y., Lee, J.-H., Cote, G. J., Wang, H., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3338 · Cited by 215
Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth
Cox, A. G., Hwang, K. L., Brown, K., Evason, K. J., Beltz, S., Tsomides, A., O’Connor, K., Galli, G. G., Yimlamai, D., Chhangawala, S., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3389 · Cited by 216
MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells
Jones, R. G., & Pearce, E. J. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.028 · Cited by 218
De novo and salvage purine synthesis pathways across tissues and tumors
Tran, D. H., Kim, D., Kesavan, R., Brown, H., Dey, T., Soflaee, M. H., Vu, H. S., Tasdogan, A., Guo, J., Bezwada, D., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.011 · Cited by 213
Critical Functions of the Lysosome in Cancer Biology
Davidson, S. M., & Heiden, M. G. V. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103101 · Cited by 214
Deoxyribonucleotide metabolism, mutagenesis and cancer
Mathews, C. K. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3981 · Cited by 208
Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine
Wang, W., Cui, J., Ma, H., Lü, W., & Huang, J. Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.684961 · Cited by 203
Negative feedback–defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL
Li, B., Li, H., Bai, Y., Kirschner‐Schwabe, R., Yang, J. J. J., Chen, Y., Lü, G., Tzoneva, G., Ma, X., Wu, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3840 · Cited by 175
Camicia, R., Winkler, H. C., & Hassa, P. O. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0474-2 · Cited by 177
Development of a stress response therapy targeting aggressive prostate cancer
Nguyen, H. G., Conn, C. S., Kye, Y., Xue, L., Forester, C. M., Cowan, J. E., Hsieh, A. C., Cunningham, J. T., Truillet, C., Tameire, F., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar2036 · Cited by 164
The relationship between the nucleolus and cancer: Current evidence and emerging paradigms
Oršolić, I., Jurada, D., Pullen, N., Oren, M., Eliopoulos, A. G., & Volarević, S. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.12.004 · Cited by 170
Nitrogen Metabolism in Cancer and Immunity
Kurmi, K., & Haigis, M. C. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.02.005 · Cited by 167
Valvezan, A. J., Turner, M., Belaïd, A., Lam, H. C., Miller, S. K., McNamara, M. C., Baglini, C. V., Housden, B. E., Perrimon, N., Kwiatkowski, D. J., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.09.013 · Cited by 163
The Untranslated Regions of mRNAs in Cancer
Schuster, S. L., & Hsieh, A. C. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.02.011 · Cited by 145
Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA -deficient cells to PARP inhibitors
Fugger, K., Bajrami, I., dos Santos, M. S., Young, S. J., Kunzelmann, S., Kelly, G. P., Hewitt, G., Patel, H., Goldstone, R. J., Carell, T., et al. (2021) · Science · doi:10.1126/science.abb4542 · Cited by 141
Taming of the beast: shaping Myc-dependent amplification
Wolf, E., Lin, C. Y., Eilers, M., & Levens, D. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.10.006 · Cited by 138
Metabolism as a Target for Modulation in Autoimmune Diseases
Huang, N., & Perl, A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.04.006 · Cited by 130
Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities
Kollareddy, M., Dimitrova, E., Vallabhaneni, K. C., Chan, A., Le, T., Chauhan, K. M., Carrero, Z. I., Ramakrishnan, G., Watabe, K., Haupt, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms8389 · Cited by 127
Protein synthesis control in cancer: selectivity and therapeutic targeting
Kovalski, J. R., Kuzuoğlu‐Öztürk, D., & Ruggero, D. (2022) · The EMBO Journal · doi:10.15252/embj.2021109823 · Cited by 121
Lv, Y., Wang, X.-S., Li, X.-Y., Xu, G., Bai, Y., Wu, J., Piao, Y., Shi, Y., Xiang, R., & Wang, L.-L. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000872 · Cited by 107
Signaling, metabolism, and cancer: An important relationship for therapeutic intervention
Vaghari‐Tabari, M., Ferns, G. A., Qujeq, D., Andevari, A. N., Sabahi, Z., & Moein, S. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30276 · Cited by 126
RNA-binding proteins, multifaceted translational regulators in cancer
Wurth, L., & Gebauer, F. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.10.001 · Cited by 121
Nucleolar stress: From development to cancer
Lafita‐Navarro, M. C., & Conacci‐Sorrell, M. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.04.001 · Cited by 109
Singleton, K. R., Crawford, L. A., Tsui, E. L., Manchester, H. E., Maertens, O., Liu, X., Liberti, M. V., Magpusao, A. N., Stein, E. M., Tingley, J. P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.022 · Cited by 102
Jung, L. A., Gebhardt, A., Koelmel, W., Ade, C. P., Walz, S., Kuper, J., von Eyss, B., Letschert, S., Redel, C., d'Artista, L., et al. (2017) · Oncogene · doi:10.1038/onc.2016.354 · Cited by 101
MYC function and regulation in physiological perspective
Jha, R., Kouzine, F., & Levens, D. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1268275 · Cited by 107
Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism
Gatto, F., Miess, H., Schulze, A., & Nielsen, J. (2015) · Scientific Reports · doi:10.1038/srep10738 · Cited by 99
MYC and therapy resistance in cancer: risks and opportunities
Donati, G., & Amati, B. B. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13319 · Cited by 104
Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion
Juvekar, A., Hu, H., Yadegarynia, S., Lyssiotis, C. A., Ullas, S., Lien, E. C., Bellinger, G., Son, J., Hok, R. C., Seth, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522223113 · Cited by 93
APC/CCDH1 synchronizes ribose-5-phosphate levels and DNA synthesis to cell cycle progression
Li, Y., Yao, C.-F., Xu, F., Qu, Y., Li, J.-T., Lin, Y., Cao, Z., Lin, P., Xu, W., Zhao, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10375-x · Cited by 96
Glutamine Metabolism in Brain Tumors
Natarajan, S. K., & Venneti, S. (2019) · Cancers · doi:10.3390/cancers11111628 · Cited by 99
Zhang, Y., Xu, Y., Lu, W., Ghergurovich, J. M., Guo, L., Blair, I. A., Rabinowitz, J. D., & Yang, X. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.002 · Cited by 96
Deoxyribonucleotides as genetic and metabolic regulators
Mathews, C. K. (2014) · The FASEB Journal · doi:10.1096/fj.14-251249 · Cited by 97
Cao, L., Weetall, M. L., Trotta, C. R., Cintron, K., Ma, J., Kim, M. J., Furia, B., ROMFO, C. M., Graci, J. D., Li, W., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0863 · Cited by 92
Qian, X., Li, X., Tan, L., Lee, J.-H., Xia, Y., Cai, Q., Zheng, Y., Wang, H., Lorenzi, P. L., & Lu, Z. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0712 · Cited by 92
A Time for MYC: Metabolism and TherapyPreprint
Dang, C. V. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.031153 · Cited by 78
Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer
Huang, F., Huffman, K. E., Wang, Z., Wang, X., Li, K., Cai, F., Yang, C., Cai, L., Shih, T. S., Zacharias, L. G., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci139929 · Cited by 73
Martin, J. L., Sanders, E. N., Moreno-Roman, P., Balachandra, S., Du, X., Koyama, L. A. J., & O’Brien, L. E. (2018) · eLife · doi:10.7554/elife.36248 · Cited by 72
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Kant, R., Manne, R., Anas, M., Penugurti, V., Chen, T., Pan, B., Hsu, C.-C., & Lin, H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.001 · Cited by 76
The Role of Translation Control in Tumorigenesis and Its Therapeutic Implications
Xu, Y., & Ruggero, D. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033420 · Cited by 67
The Interplay between Myc and CTP Synthase in Drosophila
Aughey, G., Grice, S. J., & Liu, J. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005867 · Cited by 69
TOR coordinates nucleotide availability with ribosome biogenesis in plants
Busche, M., Scarpin, M. R., Hnasko, R. M., & Brunkard, J. O. (2021) · The Plant Cell · doi:10.1093/plcell/koab043 · Cited by 66
Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDH
Allen, E. L., Ulanet, D., Pirman, D. A., Mahoney, C. E., Coco, J., Si, Y., Chen, Y., Huang, L., Ren, J., Choe, S. E., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.052 · Cited by 69
Le, T. M., Poddar, S., Capri, J. R., Abt, E. R., Kim, W., Liu, W., Uong, N. T., Cheng, C., Braas, D., Nikanjam, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00221-3 · Cited by 67
Menin enhances c-Myc-mediated transcription to promote cancer progression
Wu, G., Yuan, M., Shen, S., Ma, X., Fang, J., Zhu, L., Sun, L., Liu, Z., He, X., Huang, D., et al. (2017) · Nature Communications · doi:10.1038/ncomms15278 · Cited by 69
The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas
D’Andrea, A., Gritti, I., Nicoli, P., Giorgio, M., Doni, M., Conti, A., Bianchi, V., Casoli, L., Sabò, A., Mironov, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11719 · Cited by 64
Rodríguez-Sánchez, I., Schafer, X., Monaghan, M., & Munger, J. C. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007569 · Cited by 67
A second Warburg‐like effect in cancer metabolism: The metabolic shift of glutamine‐derived nitrogen
Kodama, M., & Nakayama, K. I. (2020) · BioEssays · doi:10.1002/bies.202000169 · Cited by 65
The crosstalk between metabolism and translation
Biffo, S., Ruggero, D., & Santoro, M. M. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.022 · Cited by 66
In vivo Reprogramming of Cancer Metabolism by MYC
Camarda, R., Williams, J. R., & Goga, A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00035 · Cited by 56
Decoding Calcium Signaling Dynamics during Drosophila Wing Disc Development
Brodskiy, P., Wu, Q., Soundarrajan, D. K., Huizar, F. J., Chen, J., Liang, P., Narciso, C. E., Levis, M., Arredondo-Walsh, N., Chen, D. Z., et al. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2019.01.007 · Cited by 57
Combined Inactivation of CTPS1 and ATR Is Synthetically Lethal to MYC-Overexpressing Cancer Cells
Sun, Z., Zhang, Z., Wang, Q.-Q., & Liu, J.-L. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-1707 · Cited by 58
Kuilenburg, A. B. P., & Meinsma, R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.05.012 · Cited by 56
De novo nucleotide biosynthetic pathway and cancer
Chen, J., Yang, S., Li, Y., Xu, Z., Zhang, P., Song, Q., Yao, Y., & Pei, H. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.04.018 · Cited by 55
The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer
Hon, K. W., Abidin, S. A. Z., Othman, I., & Naidu, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.768861 · Cited by 53
Maharjan, A., Singhvi, M. S., & Kim, B. S. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00333 · Cited by 50
Interplay Between Metabolism and Oncogenic Process: Role of microRNAs
Arora, A., Singh, S. P., Bhatt, A. N., Pandey, S., Sandhir, R., & Dwarakanath, B. S. R. (2015) · Translational Oncogenomics · doi:10.4137/tog.s29652 · Cited by 43
Deregulated transcription factors in the emerging cancer hallmarks
Hasan, A., Khan, N. A., Shahab Uddin, M. S., Khan, A. Q., & Steinhoff, M. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.001 · Cited by 45
MYC sensitises cells to apoptosis by driving energetic demand
Edwards-Hicks, J., Su, H., Mangolini, M., Yoneten, K. K., Wills, J. C., Blanco, G. R., Young, C. S., Cho, K., Barker, H. S., Muir, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32368-z · Cited by 45
Zhang, F., Patel, D. M., Colavita, K., Rodionova, I. A., Buckley, B., Scott, D. A., Kumar, A., Shabalina, S. A., Saha, S., Chernov, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms8517 · Cited by 44
Taylor, H. E., Simmons, G. E., Jr., Mathews, T. P., Khatua, A. K., Popik, W., Lindsley, C. W., D’Aquila, R. T., & Brown, H. A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004864 · Cited by 43
O’Connor, J. T., Stevens, A. C., Shannon, E. K., Akbar, F. B., LaFever, K. S., Narayanan, N. P., Gailey, C. D., Hutson, M. S., & Page, A. W. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.06.020 · Cited by 42
Human PRPS1 filaments stabilize allosteric sites to regulate activity
Hvorecny, K. L., Hargett, K., Quispe, J. D., & Kollman, J. M. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-00921-z · Cited by 41
A journey into the regulatory secrets of the de novo purine nucleotide biosynthesis
Ayoub, N., Gedeon, A., & Munier‐Lehmann, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1329011 · Cited by 43
The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment
Bartish, M., Abraham, M. J., Gonçalves, C., Larsson, O. S., Rolny, C., & Rincon, S. V. D. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00567-5 · Cited by 42
Yu, Y., Tian, L., Xiao, F., Cheng, J. Q., Gong, Y., Liu, X., Zhang, Z., Yang, X., He, S., Li, C., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.052 · Cited by 40
Hepatic mTORC1 signaling activates ATF4 as part of its metabolic response to feeding and insulin
Byles, V., Cormerais, Y., Kalafut, K., Barrera, V., Hughes Hallett, J. E., Sui, S. H., Asara, J. M., Adams, C. M., Hoxhaj, G., Ben-Sahra, I., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101309 · Cited by 44
Wang, J., Farris, A. B., Xu, K., Wang, P., Zhang, X., Duong, D. M., Yi, H. L., Shu, H. G., Sun, S., & Wang, Y. (2016) · Nature Communications · doi:10.1038/ncomms11795 · Cited by 37
Xue, C., Yu, D. M. T., Gherardi, S., Koach, J., Milazzo, G., Gamble, L. D., Liu, B., Valli, E., Russell, A. J., London, W. B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10709 · Cited by 36
Metadata
- Authors
- Cunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M., & Ruggero, D.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Ruggero, Davide
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 157
- Issue
- 5
- Pages
- 1088-1103
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4140650
- OpenAlex
- W2073120856
- Cited by
- 260
- References
- 57
- Citations by year
- 2026: 20 · 2025: 18 · 2024: 30 · 2023: 17 · 2022: 24 · 2021: 24 · 2020: 20 · 2019: 23 · 2018: 13 · 2017: 16 · 2016: 25 · 2015: 23 · 2014: 7
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-07-31)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Leukemia and Lymphoma Society
- Gladstone Institutes
- Regeneron Pharmaceuticals
- National Institutes of Health
- University of California, Davis
- National Human Genome Research Institute (U01HG004085, U01HG004080)
- National Cancer Institute (R01 CA130812, R01CA140456, R01CA154915, R01CA154916)
- National Center for Research Resources (U42RR024244)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- PRPS2, phosphoribosylpyrophosphate synthetase, MYC oncogene, nucleotide synthesis, protein synthesis, rate-limiting enzyme, eIF4E, translation initiation, anabolic metabolism, carcinogenesis, tumor cell proliferation
- MeSH terms
- Animals, B-Lymphocytes, Base Sequence, Burkitt Lymphoma, Cells, Cultured, Humans, Isoenzymes, Molecular Sequence Data, Nucleotides, Ribose-Phosphate Pyrophosphokinase, Protein Biosynthesis, Proto-Oncogene Proteins c-myc, Mice, Knockout, 5' Untranslated Regions, Eukaryotic Initiation Factor-4E, NIH 3T3 Cells, Cell Line, Tumor, Mice, Embryonic Stem Cells, Gene Knockdown Techniques, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
